Standard | 2015 | 2019 | Comment | |
---|---|---|---|---|
Quality of TB surveillance data | ||||
B1.1 | Case definitions are in line with WHO guidelines | + | + | Adoption of WHO definitions (2013) |
B1.2 | The TB surveillance system is designed to account for a minimum of variables for reported TB cases | ± | + | Adoption of WHO definitions (2013) |
B1.3 | All data to be submitted periodically has been received and processed at the national level | x | + | 100% of reports received in DHIS2 (2018) |
B1.4 | The data presented in the quarterly reports are accurate, comprehensive, consistent internally | x | + | Quarterly reports show discrepancies in places that are corrected during supervision |
B1.5 | The data contained in the national database are accurate, comprehensive, consistent internally and without duplicates | NA | NA | Not applicable for a paper-based system |
B1.6 | Tuberculosis surveillance data are externally consistent (5–15% of cases are children) | + | + | 6.5% of our patients were in 2018 |
B1.7 | The number of TB cases reported is consistent internally | ± | ± | Quarterly reports show discrepancies in places that are corrected during supervision. |
B1.8 | All cases of tuberculosis diagnosed are reported | x | x | Tuberculosis is under surveillance and is considered a priority for the Ministry of Health. There is no ministerial decree making TB disease notification mandatory. |
B1.9 | People have good access to health care | x | x | - The under-five mortality rate (probability of dying before the age of 5 per 1000 live births) is 86 per 1000 in 2017 - 54% of health spending was direct payments in 2015 |
Quality and coverage of civil state facts | ||||
B1.10 | The civil registration system is of excellent quality and provides broad national coverage | x | x | Guinea has a civil registration system, and there is a register of deaths at the morgue level where deaths are recorded. The causes of death are not recorded. |
Surveillance of Multidrug-resistant Tuberculosis | ||||
B2.1 | Surveillance data provide a direct measure of multi-drug resistant TB cases among new cases | x | x | In our context, not all patients are systematically tested. The Xpert MTB test is indicated for a number of cases. No drug resistance studies have yet been conducted in Guinea |
Tuberculosis/HIV surveillance | ||||
B2.2 | Surveillance data provide a direct measure of HIV prevalence in TB patients | The HIV test coverage was 90% in 2018 | ||
Tuberculosis surveillance in children | ||||
B2.3 | Surveillance data for children reported to be TB (aged between 0 and 14 by definition) are reliable and accurate, AND all cases of childhood tuberculosis diagnosed are reported | x | x | The ratio of (0–4:5–14 years) patients was 0.38 in 2018 |